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Background: Yeast has numerous mechanisms to survive stress. Deletion of myosin type II (myo1Δ) in
Saccharomyces cerevisiae results in a cell that has defective cytokinesis. To survive this genetically induced stress, this
budding yeast up regulates the PKC1 cell wall integrity pathway (CWIP). More recently, our work indicated that TOR,
another stress signaling pathway, was down regulated in myo1Δ strains. Since negative signaling by TOR is known
to regulate PKC1, our objectives in this study were to understand the cross-talk between the TOR and PKC1
signaling pathways and to determine if they share upstream regulators for mounting the stress response in
myo1Δ strains.
Results: Here we proved that TORC1 signaling was down regulated in the myo1Δ strain. While a tor1Δ
mutant strain had increased viability relative to myo1Δ, a combined myo1Δtor1Δ mutant strain showed
significantly reduced cell viability. Synthetic rescue of the tor2-21ts lethal phenotype was observed in the
myo1Δ strain in contrast to the chs2Δ strain, a chitin synthase II null mutant that also activates the PKC1
CWIP and exhibits cytokinesis defects very similar to myo1Δ, where the rescue effect was not observed. We
observed two pools of Slt2p, the final Mitogen Activated Protein Kinase (MAPK) of the PKC1 CWIP; one pool
that is up regulated by heat shock and one that is up regulated by the myo1Δ stress. The cell wall stress
sensor WSC1 that activates PKC1 CWIP under other stress conditions was shown to act as a negative
regulator of TORC1 in the myo1Δ mutant. Finally, the repression of TORC1 was inversely correlated with the
activation of PKC1 in the myo1Δ strain.
Conclusions: Regulated expression of TOR1 was important in the activation of the PKC1 CWIP in a myo1Δ
strain and hence its survival. We found evidence that the PKC1 and TORC1 pathways share a common
upstream regulator associated with the cell wall stress sensor WSC1. Surprisingly, essential TORC2 functions
were not required in the myo1Δ strain. By understanding how yeast mounts a concerted stress response,
one can further design pharmacological cocktails to undermine their ability to adapt and to survive.
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The calcium-dependent protein kinase (Pkc1p) and
target-of-rapamycin (TOR) signaling pathways are con-
served in yeast and other fungi and are important for
stress response and fungal survival. In addition to regu-
lating growth and metabolic activity in normal cells,
these pathways also regulate the cellular response to* Correspondence: jose.rodriguez123@upr.edu
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distribution, and reproduction in any mediumtransient cell wall stress during the normal yeast life
cycle, and during exposure to heat shock, cell wall dam-
age, or other stressors that can compromise cellular in-
tegrity [1-3]. Our studies with myosin type II-deficient
(myo1Δ) strains of the budding yeast Saccharomyces cer-
evisiae, which we have characterized previously as stress
mutants, showed that the Pkc1p pathway is activated
and essential for myo1Δ strain survival [4-6]. It has been
our contention that this activation is due to cell wall
stress caused by morphological abnormalities in the lat-
eral cell wall and bud neck architecture [7,8]. InCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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types of environmental stress, Rho1p activates the PKC1
cell wall integrity pathway (CWIP), which in turn acti-
vates Slt2p (Mpk1p), the Serine/Threonine (Ser/Thr)
MAPK at the end of this cascade [1-3]. This leads to
transcriptional up regulation of cell wall-related genes by
the Rlm1p transcription factor [9-12]. In addition to
regulating the genetic program for cell wall integrity
through the transcription factor Rlm1p [9,13,14], Slt2p
may also modulate PKC1 activity indirectly by a previ-
ously proposed feedback mechanism that phosphorylates
and down regulates the Rho1p GDP-GTP Exchange Fac-
tor (GEF) Rom2p [15]. Rho1p also functions as the regu-
latory subunit of Fks1p, a β-1,3-glucan synthase for
lateral cell wall fortification [16].
In prior studies, we have shown that similar to wild-
type (wt) cells under stress conditions, the myo1Δ mu-
tant (a genetically induced stress caused by the deletion
of myosin II heavy chain that inhibits normal cytokinetic
ring assembly) also activates the PKC1 CWIP, but
uses a different repertoire of genes [4,5]. Further char-
acterization of the genes of the myo1Δ mutant at the
post-transcriptional level showed that only a subset of









Figure 1 General Description of the known interactions between themutant may serve as a simplified model for studying the
cell wall stress response. Furthermore, we found that
translation and ribosome biogenesis were down regu-
lated in the myo1Δ strain [17]. This observation led us
to investigate the role of TOR in the myo1Δ strain sur-
vival and how it may complement the reduced CWIP
response.
Yeast TOR consists of two proteins - Tor1p and
Tor2p - which are contained in two protein complexes
TORC1 and TORC2 [18,19]. The TORC1 complex that
is sensitive to rapamycin treatment contains proteins
Tor1p or Tor2p, Kog1p, Tco89p and Lst8p [18,20-22].
TORC2 that is resistant to rapamycin treatment contains
Tor2p, Avo1p, Avo2p, Avo3p, Bit61p, and Lst8p [18,20].
Recent subcellular localization studies showed that
Tor1p was concentrated near to the vacuolar membrane
while Tor2p was predominantly in punctuate structures
near to the cytoplasmic surface of the plasma membrane
[23]. Their differences in composition, sensitivity to
rapamycin, and cellular localization support the idea that
they function as two separate complexes [18,20,23].
TOR is important for nutrient sensing and is believed to
play an important role in life span extension [24-27].
While TOR is conserved structurally and functionallys
wall 
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identical and warrant careful characterization of TOR
from both species.
Rho1p is regulated by two mechanisms, a TOR-
independent mechanism that is activated by cell wall
stress (discussed above) and a separate TORC2-
dependent mechanism that regulates actin cytoskeleton
reorganization through the Rho1p-dependent activation
of PKC1 [28]. In this latter pathway, Rom2p activity is
indirectly modulated by the essential phosphatidylinosi-
tol kinase TORC2 via a GTPase switch consisting of
Rho1p, Rho2p, Rom2p, and Sac7p (a GTPase activating
protein of Rho1p) [29,30]. In short, the TORC2-
dependent association of Rho1p (and Rho2p) with the
Rom2p phosphatidylinositol-binding domain promotes
Rom2p activation and downstream events [30,31]. In
this manner Rom2p functions as the relay by which
TORC2 regulates polarization of the actin cytoskeleton
via Pkc1p. Therefore, functional interconnections be-
tween Pkc1p and TORC2 have been proposed through a
mechanism integrated by the Rho1p-Rom2p complex
[30,31] (Figure 1).
The stress sensor proteins Wsc1p, Wsc2p, Wsc3p,
Mid2p and Mtl1p are involved in the activation of cell
integrity signaling [2,32-37]. These cell surface sensors
span the plasma membrane and are attached to the
extracellular cell wall. The Mid2p homologue Mtl1p,
that shares 50% sequence identity with Mid2p, appears
to have a minor role in PKC1 signaling [14]. These sen-
sors react differently under specific stress conditions
[37]. It has been reported that cells lacking WSC1 are
hypersensitive to drugs interfering with the cell wall and
plasma membrane like Calcofluor white, Congo red,
Caspofungin, Chlorpromazine and tea tree oil [1,38-40].
Additionally, Wsc1p responds to hypo-osmotic and alka-
line pH conditions [39,41]. A mid2Δ mutant is hyper-
sensitive to pheromone treatment, is hyperresistant to
Calcofluor white, tea tree oil and Congo Red, and it
senses acidic conditions and vanadate [32,37,39,40,42-
44]. Wsc1p and Mid2p are also involved in the response
to heat shock [2,33,35,45]. WSC2 and WSC3 act as sup-
pressors of mutants defective in glycerol synthesis [37],
while Mtl1p is associated with response to oxidative
stress and glucose starvation [46,47]. The Wsc family of
proteins and Mid2p have been shown to interact with
specific signaling proteins that transmit stress signals
from the fungal cell wall sensors to the Pkc1p and TOR
signaling pathways. For example, Rom2p, the GEF that
regulates Pkc1p, physically interacts with Wsc1p, Wsc2p,
and Mid2p to activate the PKC1 CWIP in the response
to cell wall stress [36,48,49]. To define the nature of
these signaling interactions in myo1Δ strains, we demon-
strate here that TORC1 and Pkc1p activities were in-
versely correlated, which suggests cross-talk between thetwo pathways. Furthermore, we found that TORC1 was
down regulated in myo1Δ strains by a mechanism that
required expression of Wsc1p but not the other cell wall
stress sensors. Surprisingly, Tor2p functions were not es-
sential for survival in myo1Δ cells.
Results
TORC1 activity is down regulated in myo1Δ strains
To test the hypothesis that the TORC1 pathway was
down regulated in the myo1Δ strain, we measured the
levels of phosphorylated or dephosphorylated Npr1p to
assess the TORC1 status [50]. TORC1 signaling regu-
lates phosphorylation of the Ser/Thr protein kinase
Npr1p at 22 potential phosphorylation sites [51,52]. At
steady state, Npr1p is maintained inactive by phosphor-
ylation [51] (Figure 2A, left diagram). Inhibition of
TORC1 activity by nutrient starvation or application of
the antiproliferative drug rapamycin results in depho-
sphorylation and subsequent activation of Npr1p by the
protein phosphatase Sit4p [50,51,53] (Figure 2A, right
diagram). To detect Npr1p in the myo1Δ strains, an ex-
pression plasmid containing a functional N-terminal
hemagglutinin (HA)-tagged NPR1 gene (HA-NPR1) was
transformed into wt and mutant strains [54].
The phosphorylation state of Npr1p can be deduced
from its relative electrophoretic mobility on SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) and
detected by Western blot analysis using an anti-HA anti-
body. In wt whole cell extracts, Npr1p was detected as a
slower-migrating band, which corresponds to the hyper-
phosphorylated form, Npr1pP (Figure 2B, lane 1). Treat-
ment of wt whole cell extracts with exogenous Calf
Intestinal Alkaline Phosphatase (PPase) converted the
slower-migrating band to a faster-migrating band which
corresponds to the in vitro dephosphorylated form,
Npr1p (Figure 2B, lane 2). Treatment of wt cell cultures
with rapamycin produced a faster-migrating Npr1p band
that co-migrated with the PPase treated band, consistent
with the inhibition of TORC1 activity by rapamycin
(Figure 2B, lane 3). This experiment established that the
activity of TORC1 could be assessed indirectly by ob-
serving the relative electrophoretic mobility of Npr1p by
SDS-PAGE [50,53].
In myo1Δ whole cell extracts, no change in the elec-
trophoretic mobility of Npr1p was observed as judged
by the co-migration of Npr1p bands in extracts from
rapamycin treated and untreated cells (Figure 2C, lanes
1 and 3). This result suggested that Npr1p is depho-
sphorylated at steady state in the myo1Δ strain. A chs2Δ
strain (a chitin synthase II null mutant defective in con-
tractile ring function) and an fks1Δ strain (a β-1,3-glucan
synthase null mutant deficient in cell wall synthesis and
maintenance) were incorporated as controls representing
strains under cell wall stress [55,56]. In contrast, the
Npr1pP
Npr1p
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Figure 2 The TORC1 pathway is down regulated in myo1Δ strains but not in other cell wall stress models. A) Schematic representation of
the TOR signaling pathway and regulation of the phosphorylation state of Npr1p following inhibition of TOR by nutrient starvation or rapamycin.
B–E) Western blot analysis of HA-NPR1 showing the difference in electrophoretic mobility of phosphorylated Npr1p (Npr1pP) and the
dephosphorylated form, Npr1p, following treatments with rapamycin, PPase or a genetic mutation of MYO1 (see Methods for details). Arrows
point to the expected positions of the Npr1pp-phosphorylated form (100 kiloDaltons, kDa) and Npr1p-dephosphorylated form (85 kDa). Protein
extracts were analyzed from A) wild-type (wt) (10 μg), B) wild-type (wt) (10ug), C) myo1Δ (40ug), and D) chs2Δ (20ug),and E) fks1Δ (20ug).
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and fks1Δ (Figure 2E) control strains behaved similar
to the wt (Figure 2B). Phosphatase treatment did not
change the electrophoretic mobility of Npr1p in the
myo1Δ extracts supporting our hypothesis that TORC1
is down regulated (Figure 2C, lanes 1 and 2). Introduc-
tion of a tor1Δ mutation into the myo1Δ strain did
not produce any change in the electrophoretic migra-
tion of Npr1p compared to the myo1Δ single mutant
(Figure 3A). This was also consistent with the notion
that TORC1 is inhibited in the myo1Δ strain. These
observations suggest that the myo1Δ strain is distinct
from the other cell wall stress models because despite
the similarity between these strains which have thePKC1 CWIP activated, the TORC1 activity was inhib-
ited in the myo1Δ strain but not in the cell wall
mutants tested (chs2Δ and fks1Δ) (see Discussion for
details).
The SIT4 gene encodes a protein phosphatase that is
responsible for dephosphorylation of Npr1p in vivo
during nutrient starvation (Figure 2A) [51]. TORC1
when active, phosphorylates Tap42p, which then binds
and keeps Sit4p inactive [57]. Thus, Sit4p activity is
negatively regulated by TORC1 [58]. In previous stud-
ies, Npr1p was shown to maintain the hyperphosphory-
lated state in a sit4Δ mutant treated with rapamycin
indicating that its dephosphorylation was directly












Figure 3 TORC1 is down regulated and Npr1p
dephosphorylation is Sit4p dependent in myo1Δ strains. Protein
extracts from A) myo1Δ (40 μg), myo1Δtor1Δ (20 μg) and B)
myo1Δsit4Δ (20 μg) mutant strains each expressing an HA-NPR1
plasmid were analyzed by Western blot. Each membrane was
probed with anti-HA and anti-PGK1 antibodies. Pgk1p was used
as a control. Arrows point to the expected positions of the
Npr1pp-phosphorylated form and Npr1p-dephosphorylated form.
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anism in myo1Δ, we conducted a Western blot analysis
of Npr1p in a myo1Δsit4Δ strain (Figure 3B). Absence
of Sit4p activity in the myo1Δ strain resulted in the ac-
cumulation of the slow-migrating hyperphosphorylated
Npr1p. This result supports that the myo1Δ depho-
sphorylation of Npr1p is via Sit4p.TOR signaling activity was previously reported to
negatively regulate the PKC1 CWIP [59] because rapa-
mycin treatment resulted in up regulation of PKC1 activ-
ity. Our new observations show that TORC1 was
repressed in myo1Δ cells while we had previously shown
that PKC1 activity was up regulated in these strains
[4,6]. To determine if the repression of TORC1 activity
in myo1Δ cells is responsible for up regulation of the
PKC1 pathway, we treated myo1Δ cells with rapamycin
and monitored Slt2p/Mpk1p hyperphosphorylation (re-
ferred to as P-Slt2p from here on) by Western blot ana-
lysis (see Methods). As previously reported, down
regulation of TORC1 activity in wt cells treated with
rapamycin resulted in up regulation of PKC1, reflected
by an accumulation of P-Slt2p (Figure 4A). In untreated
myo1Δ cells, there was an accumulation of P-Slt2p as
described previously (Figure 4A). There was no signifi-
cant increase in P-Slt2p levels following rapamycin treat-
ment in these cells (Figure 4B, lanes 1 and 2). This
observation supports the aforementioned result [59] that
down regulation of TORC1 activity is correlated to the
up regulation of PKC1.
To analyze this putative cross-talk further, we assayed
the relative levels of P-Slt2p in a myo1Δtor1Δ strain. In
the absence of Tor1p, a myo1Δtor1Δ strain maintained
significant steady state levels of P-Slt2p at approxi-
mately 50% of the myo1Δ- levels (Figure 4B, lane 5),
while treatment with rapamycin did not generate a sig-
nificant change in these levels (Figure 4B, lane 6). A
tor1Δ single mutant activated PKC1 at low levels
(Figure 4B, lanes 3 and 4).
To determine if these strains presented a growth
defect we tested wt, myo1Δ, tor1Δ and myo1Δtor1Δ
strains for cell viability using a serial dilution assay
(Figure 4C). The myo1Δ strain exhibited a viability
range similar to the wt strain. Surprisingly, the tor1Δ
strain showed increased viability through the 102
cells/ml range, consistent with previous studies that
showed that Tor1p functions were not essential for
cell viability. Despite having P-Slt2p present
(Figure 4B, lane 5) the myo1Δtor1Δ strain presented a
reduction in cell viability of approximately four orders
of magnitude (Figure 4C, bottom row). Therefore,
down regulation of TORC1 appears to be favorable to
maintain viability in the myo1Δ strain while a
complete absence of Tor1p in this strain is detrimen-
tal. These results imply that Tor1p may have a pre-
dominant role in the TORC1 functions with less
activity attributed to the Tor2p in this complex. How-
ever, the residual activity in the TORC1 complex was
essential for myo1Δtor1Δ strain survival because five
days treatment with the IC50 of rapamycin (44nM)
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Figure 4 Inverse correlation between TORC1 and PKC1 activities. A) The PKC1 pathway was activated in wt cells upon inhibition of TORC1
with rapamycin. This pathway is constitutively activated in myo1Δ cells. A–B) All histograms show the ratio of the intensities of each P-Slt2p band
relative to the intensity of its Pgk1p loading control, averaged from duplicate experiments. Error bars represent STDError mean. B) Steady state
levels of hyper phosphorylated Slt2p (P-Slt2p, 55 kDa) were assayed by Western blot using equal amounts of protein extract (50 μg) from myo1Δ,
tor1Δ, and myo1Δtor1Δ strains treated with rapamycin (+) or with DMSO alone (-). Pgk1p was used as a loading control. C) Limiting dilution
growth assay on agar medium measuring relative viability of wt, myo1Δ, tor1Δ, and myo1Δtor1Δ strains. 10-fold dilutions are indicated at the top
of the image (see Methods for details).
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lethality of a tor2-21ts allele at 37°C is rescued by myo1Δ
TORC1 is not essential in wt [60] or myo1Δ strains. In
contrast, TORC2 carries out essential functions in yeastcells that are not shared with TORC1 [21,22,61]. Growth
at the permissive (26°C) and restrictive (37°C) tempera-
tures was assayed for strains wt, myo1Δ, chs2Δ (each
bearing a genomic copy of wild type TOR2), SH121










































Figure 5 Synthetic rescue of the tor2-21ts phenotype by myo1Δ. Assay for viability of yeast strains by growth at 26°C and 37°C. Strains tested
were wt (YJR24), myo1Δ, chs2Δ, wt’ (JK9-3da), tor2Δ ptor2ts, wt ptor2ts, myo1Δ ptor2ts, chs2Δ ptor2ts, tor2Δ pTOR2, myo1Δtor2Δptor2ts. A) Rescue
of tor2–21ts lethality at 37°C by myo1Δ in the YJR13 strain background (top) and SH121 strain background (bottom). B) Limiting dilution growth
assay on agar medium measuring relative viability at 26°C and 37°C for tor2Δ ptor2ts, myo1Δtor2Δptor2ts, and myo1Δtor2Δptor2tspMYO1 strains.
10-fold dilutions are indicated at the top of the image (see Methods for details). C) Regulation of Slt2p phosphorylation in myo1Δ strains
expressing the tor2–21ts mutation at 37°C. Steady state levels of P-Slt2p in wt, myo1Δ, tor2Δ ptor2ts, and myo1Δ ptor2ts were analyzed by
Western blot as described previously from cultures grown at 26°C and 37°C. Pgk1p was used as a loading control. Histograms show the ratio of
the relative intensities of each P-Slt2p band and its Pgk1p loading control, averaged from duplicate experiments. Error bars represent
STD Error Mean.
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http://www.biomedcentral.com/1471-2121/13/13(acontrol tor2Δ strain that contains a plasmid-borne
copy of a temperature_sensitive tor2-21 allele, ptor2ts)
and combination strains bearing also the ptor2ts plasmid.
Since TORC2 is responsible for essential cellular func-
tions, the expected outcome was that repression of the
tor2-21ts allele at 37°C would be lethal in any strain. Par-
ental strains and mutant strains bearing ptor2ts were
therefore assessed for growth on agar at 26°C and 37°C.
As expected, the wt, myo1Δ, and chs2Δ strains did not
exhibit temperature sensitive growth (Figure 5A, top
row). The tor2Δ ptor2ts (control), wt ptor2ts, and chs2Δ
ptor2ts strains were viable at 26°C and temperature sen-
sitive for growth at 37°C indicating dominance of the
tor2-21ts mutation (Figure 5A, upper left and upper right
respectively). In contrast, the myo1Δ ptor2ts strain pre-
sented viable growth at both temperatures (Figure 5A,
top row). The suppression of tor2-21ts lethality by
myo1Δ in this strain (YJR13) was also confirmed in the
SH121 strain background (Figure 5A, bottom left and
bottom right, respectively) to exclude genetic back-
ground effects. Growth was also assessed on Leucine
dropout medium plates to ascertain that strains trans-
formed with the ptor2ts allele were expressing the plas-
mid, as observed by the normal growth at 26°C
[Additional file 1, left plates], and again that the tor2-
21ts defect was suppressed in the absence of the MYO1
gene at 37°C independently of the strain background
[Additional file 1, right plates]. The positive genetic
interaction between myo1Δ and tor2-21ts mutations was
reverted by complementation with a plasmid-borne copy
of the wild type MYO1 gene in myo1Δtor2Δptor2tsp-
MYO1 (SH121) (Figure 5B) and also myo1Δptor2tsp-
MYO1 (YJR13) strains (data not shown).
TORC2 has been shown to have a strong regulatory
effect on PKC1 activity in cell wall mutants [29,30]. To
explain the observed synthetic rescue of tor2-21ts lethal-
ity by myo1Δ, we conducted a Western blot analysis of
P-Slt2p levels in the wt, myo1Δ (Figure 5C, box1), tor2Δ
ptor2ts and myo1Δ ptor2ts strains (Figure 5C, box 2) at
the permissive temperature. Wt and tor2Δ ptor2ts strains
showed similarly low P-Slt2p levels consistent with
growth under non-stress conditions (Figure 5C, box 1
and box 2 respectively). The myo1Δ (Figure 5C, box1)
and myo1Δ ptor2ts (Figure 5C, box2) strains both pre-
sented a higher level of P-Slt2p relative to wt strains at
26°C, which was also consistent with previous observa-
tions that PKC1 is activated in these strains (Figure 4A,
lane 3).
To assess if rescue of tor2-21ts lethality at the restrict-
ive temperature by myo1Δ was accompanied by a change
in PKC1 activity levels, P-Slt2p was analyzed in whole
cell extracts from cultures taken at 37°C (Figure 5C
boxes 3 and 4). The temperature shift to 37°C produced
an increase in P-Slt2p levels in all four strainsattributable to the heat shock effect that is known to ac-
tivate the PKC1 pathway [1,62]. This suggests that there
may exist two pools of Slt2p, one that is activated by the
myo1Δ mutation and one that is activated (or phos-
phorylated) by the heat stress. Densitometric quantifica-
tion and normalization of autoradiographs from
duplicate experiments established that P-Slt2p levels in
the myo1Δ ptor2ts strain at 37°C were 5-fold higher than
in the tor2Δ ptor2ts strain yet were very similar to the
myo1Δ single mutant strain at 37°C (Figure 5C, bottom
panel). However, when we compared P-Slt2p levels be-
tween the tor2Δ ptor2ts and myo1Δtor2Δptor2ts strain,
there was no significant difference between them sup-
porting that the rescue effect was not due to Tor2p-
dependent P-Slt2p up regulation (Figure 5C, box 5) or
differences in P-Slt2p levels.
Evidence for a cross-talk between Pkc1p, TORC1, and cell
wall stress sensor Wsc1p
Inhibition of TOR functions activates multiple cell wall
stress sensor proteins located in the plasma membrane
that interact with signaling intermediates through their
C-terminus in the cytoplasm [59]. Cell wall stress sensor
proteins that belong to the Wsc family and also include
the Mid2 proteins, signal positively to activate the PKC1
CWIP [2,32-37]. Under cell wall stress conditions,
Wsc1p, Wsc2p and Mid2p are reported to be the princi-
pal sensors responsible for activating this pathway
[36,48,49]. Consistent with the notion that cell wall
stress sensors may mediate the stress response in myo1Δ
strains, we have presented evidence that the PKC1
CWIP is activated and essential [4-6] and that TORC1
activity is down regulated in myo1Δ strains (this study).
To test if cell wall stress sensor proteins could, by a
cross-talk mechanism, be involved in down regulating
the TOR pathway, the myo1Δ mutation was inserted in
wsc1Δ, wsc2Δ, wsc3Δ and mid2Δ mutant strains by
standard genetic techniques (see Methods). The single
mutants (wsc1Δ, wsc2Δ, wsc3Δ, mid2Δ) and their corre-
sponding double mutant strains (myo1Δwsc1Δ,
myo1Δwsc2Δ, myo1Δwsc3Δ, myo1Δmid2Δ) were tested
for TORC1 activity and cell viability (only the results for
Wsc1p are shown, Figure 6).
Relative TORC1 activity levels for the wt and myo1Δ
strains were previously shown (Figures 2B and 2C re-
spectively), while the results for myo1Δwsc2Δ,
myo1Δwsc3Δ and myo1Δmid2Δ strains were also con-
sistent with down regulated TORC1 activity in these
strains (data not shown). In contrast, the myo1Δwsc1Δ
double mutant strain exhibited a result that was con-
sistent with a fully active TORC1 (Figure 6A, lane 1)
as judged by the relative decrease in electrophoretic
mobility normally exhibited by Npr1pp, and the
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Figure 6 Negative interaction between TORC1 activity and the Wsc1p cell wall stress sensor. A) Western blot analysis of Npr1p
electrophoretic mobility in wsc1Δ mutant strains (see methods for details). Whole cell protein extracts were prepared from myo1Δ(40 μg),
wsc1Δ(20 μg) and myo1Δwsc1Δ(20 μg) strains expressing the HA-NPR1 as described. Reactivation of TORC1 is observed in a myo1Δwsc1Δ strain
and dephosphorylation occurs upon Inhibition of TORC1 by rapamycin. A wsc1Δ strain shows down regulation of TORC1. B) Western blot analysis
of P-Slt2p levels in wsc1Δ mutant strains. 50 μg whole cell protein extracts were analyzed per lane. Histograms show the ratio of the relative
intensities of each P-Slt2p band and its Pgk1p loading control, averaged from duplicate experiments. Error bars represent STDError mean. C)
Limiting dilution growth assay on agar medium measuring relative viability of wt, myo1Δ, wsc1Δ and myo1Δwsc1Δ strains at 26°C. 10-fold
dilutions are indicated at the top of the image (see Methods for details).
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the myo1Δ and wsc1Δ strains (Figure 6A, lanes 3 and 4),
preliminary results show that wsc2Δ, wsc3Δ, and mid2Δ
single mutant strains (data not shown) exhibited a
rapamycin-insensitive Npr1p electrophoretic mobility
that was consistent with down regulation of TORC1.
These results indicate that absence of these cell wallstress sensors represents a cell stress and supports the
idea that they also play a role during normal cell growth.
We therefore conclude from these results that Wsc1p
may be associated with the regulation of TORC1 in both
the wt and myo1Δ strains.
Because TORC1 and PKC1 activities maintain an in-




































Figure 7 Dephosphorylation of eIF2α-P confirms activation of
TORC1 activity in myo1Δwsc1Δ. Western blot analysis of steady
state levels of eIF2α and its phosphorylated form eIF2α-P was
conducted with 50 μg per lane of whole cell protein extract derived
from wt, myo1Δ, wsc1Δ and myo1Δwsc1Δ strains. Pgk1p was used
as a loading control. Histograms show the ratio of the relative
intensities of each eIF2α band and its Pgk1p loading control,









Figure 8 Schematic representation of the proposed regulation
of TOR and Pkc1p in the myo1Δ strain. The myo1Δ deficiency
(yellow ray) creates a cell wall stress signal that is transduced
through the Wsc1p stress sensor from the Rho1p-GEF Rom2p to
Rho1p which activates the PKC1 CWIP. Activation of Rho1p also
leads to activation of Fks1p activity and cell wall synthesis.
Regulation of cell wall integrity and actin cytoskeletal reorganization
by Pkc1p could explain the synthetic rescue effect of myo1Δ in a
tor2–21ts strain. A novel negative regulation of TORC1 by Wsc1p was
observed in the myo1Δ strain. We propose that the negative
regulation of TORC1 by Wsc1p involves a novel interacting protein
of Wsc1p labelled here as “X”.
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would exert an inhibitory effect on the PKC1 pathway.
Consistent with this hypothesis, the myo1Δwsc1Δ strain
failed to activate the PKC1 pathway as evidenced by un-
detectable levels of P-Slt2p relative to a myo1Δ single
mutant where PKC1 was activated (Figure 6B). Cell via-
bility analysis revealed a reduction in growth of approxi-
mately one order of magnitude in the myo1Δwsc1Δ
double mutant strain relative to the myo1Δ strain and
two orders of magnitude relative to wt and wsc1Δ strains
that grew comparably well (Figure 6C).
We then tested eIF2α phosphorylation levels as an
additional readout of TORC1 status [63]. Previous stud-
ies showed that TORC1 down regulation in myo1Δ was
evidenced by a large (2 fold) accumulation of phos-
phorylated eIF2α (eIF2α-P) produced by a TOR-
dependent activation of Gcn2p protein kinase (Figure 7,
top panel) [17]. The myo1Δwsc1Δ mutant combination
that restored wild type electrophoretic mobility to Npr1p(Figure 6A) also restored eIF2α-P to its active unpho-
sphorylated state, eIF2α (Figure 7, top panel, lane 4),
thereby confirming that TORC1 was being reactivated in
this mutant. Likewise, the accumulation of eIF2α-P in
the wsc1Δ mutant confirmed that TORC1 activity was
down regulated in this mutant (Figure 7, top panel, lane
3). Control extracts from the wt and myo1Δ strains were
consistent with previously reported results [17]. Total
eIF2α confirmed that the proposed changes in eIF2α-P
were due to phosphorylation rather than a change in
steady state levels of eIF2α (Figure 7, middle panel).Discussion
Yeast cells must respond rapidly and effectively to altera-
tions in the environment in order to survive stressful
conditions. These processes require the involvement of
signal transduction pathways such as TOR and PKC1.
The PKC1 dependent CWIP is the first line of response
to cell wall damage in the yeast Saccharomyces cerevisiae
[13,14]. Transduction of the signal begins with the cell
wall stress sensor proteins Wsc1p and Mid2p at the
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Rho1p to the PKC1 CWIP that ends with activation of
the MAP kinase, Slt2p [13,48] (Figure 1). Downstream,
the transcription factor Rlm1p activates nuclear genes
involved in cell wall synthesis and remodeling to pro-
duce a cell wall stress response that increases the sur-
vival potential of the yeast cell [9,10]. We have shown in
prior studies that the PKC1 pathway is continuously
activated in myo1Δ strains [4,6]. This response is further
characterized here in the myo1Δ strains. In addition to
the up regulation of the CWIP we found that TORC1
was down regulated to enhance cell survival and we pro-
vide evidence of cross-talk between the two signaling
pathways.
Npr1p is a protein kinase that regulates the amino acid
permease Gap1p to transport secondary nitrogen
sources into the cell for the restoration of amino acid
precursor levels and protein synthesis [51,64,65]. When
TORC1 is down regulated by nutrient starvation or
rapamycin treatment, Npr1p becomes dephosphorylated
by the protein phosphatase Sit4p, thereby activating its
biochemical function [50,51,53] Furthermore, inactiva-
tion of TORC1 results in downregulation of ribosome
and protein synthesis [59]. When we assayed the relative
status of TORC1 activity in a myo1Δ strain, we observed
that Npr1p was maintained in the dephosphorylated
state and demonstrated that the Npr1p phosphorylation
state was directly dependent on TORC1 and Sit4p activ-
ities. Therefore, we established that the TORC1 complex
is found in a predominantly inactive state in the myo1Δ
strain. The implications of such a metabolic state led us
to believe that the survival of this strain is directly linked
to this observation. However, the complete absence of
Tor1p by genetic deletion (tor1Δ) was detrimental for
survival of the myo1Δ strain, supporting that a precise
level of TORC1 activity must be maintained for its sur-
vival. Furthermore, complete inhibition of TORC1 activ-
ity by rapamycin treatment of a myo1Δtor1Δ strain was
lethal for growth, further supporting the idea that min-
imal levels of TORC1 activity are essential. Conversely,
the tor1Δ single mutant was shown to acquire increased
fitness, which was consistent with the proposed role of
mTOR and TOR in regulating longevity and replicative
life span extension respectively [24-27].
It was previously known that the TORC1 pathway
plays a role in the response to cell wall stress by a nega-
tive regulation of the PKC1 CWIP under nutrient rich
conditions [59] (Figure 1). Under myo1Δ conditions, we
observed a clear inverse biochemical correlation between
TORC1 and Pkc1p activities. This raised the question, is
there a common upstream regulator of the two path-
ways? Our results are strongly suggestive that Wsc1p
acts as a common upstream regulator of TORC1 and
PKC1 by exerting a positive role in the activation of thePKC1 CWIP and a negative role in the down regulation
of TORC1 by an unknown mechanism. We do not
propose that TORC1 and Wsc1p interact directly. Most
likely, the mechanism involves an undetermined protein
interactor of Wsc1p (labeled “X” in Figure 8). Recently,
we have identified several novel Wsc1p interacting pro-
teins (unpublished results) and suspect that some may
function as a signaling intermediate between Wsc1p and
TORC1. However, pending future studies, it is not
known whether or not these Wsc1p interactors inhibit
TORC1.
Our findings showed that chs2Δ and fks1Δ mutant
strains strongly activated the PKC1 CWIP yet main-
tained normal TORC1 activity levels. We are therefore
confronted with variable signaling outputs exiting from
the cell wall stress sensors. In particular, disruption of
cell wall integrity by these mutants leads to activation of
the PKC1 CWIP; however, only the disruption of cyto-
kinesis in a myo1Δ strain leads to both activation of the
PKC1 CWIP and down regulation of TORC1 (Figure 8).
This finding is consistent with the transcriptional pro-
files we have determined previously, where myo1Δ only
regulated half of the CWIP fingerprint genes, while
fks1Δ and chs2Δ profiles were more like other cell wall
damage profiles [4,5]. This reinforces the idea that
myo1Δ activates a cell signaling program that is distinct
from other cell wall mutants. We propose that in
addition to its filament assembly function, the tail do-
main may serve as a scaffold (or guide) for the assembly
of interacting protein complexes at the cytokinetic ring
that are important for myosin function [66]. Therefore,
disruption of these putative protein assemblies by a gen-
etic deletion of the MYO1 gene may activate the cell wall
stress sensors Wsc1p and Mid2p in a different manner
than in the chs2Δ and fks1Δ mutants. The non-muscle
myosin heavy chain (Myo1p) of budding yeast has been
shown to have independent functions associated with
the head and tail domains of the protein [67]. The tail
domain contains a Minimum Localization Domain
(MLD) that is sufficient to target the myosin heavy chain
to the bud neck independently of the actin-binding site
that is encoded within the head domain [68]. Therefore,
despite the common activation of the PKC1 CWIP
among the myo1Δ, chs2Δ and fks1Δ mutant strains, we
hypothesize that the inhibition of TORC1 by Wsc1p is
unique to the myo1Δ mutant and may be triggered by
the disruption of specific protein-protein interactions in
the putative Myo1p scaffold at the cytokinetic ring.
The final question that arises from these results is,
how does the myo1Δ mutant rescue tor2-21ts lethality?
Strains that carry the temperature-sensitive gene of
TOR2 (tor2ts) arrest growth at the restrictive tem-
perature (37°C). This lethality is thought to be caused by
the lack of TORC2 activity, decreased RHO1 activation
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due to cell wall defects [69]. The lethality has been
shown to be rescued in several different ways. One way
is by growth on nonfermentative carbon sources (i.e.
raffinose) but not by nonfermentable carbon sources
(i.e. glycerol or ethanol) [69]. A second way in which
tor2ts lethality can be circumvented is by treatment with
agents that cause cell integrity stress (i.e. 0.005% SDS)
[30]. A third way in which the tor2ts lethality can be
rescued is by the osmotic stabilizer, sorbitol, again sug-
gesting that the cell wall is somehow compromised.
Finally, there are several genes that have been shown
to suppress the lethality of tor2ts lethality. One example
is yeast PAS kinase overexpression (a gene involved in
glucose partitioning in the cell) which is thought to
suppress the tor2ts lethality by RHO1-dependent activa-
tion of PKC1 and actin rearrangement, activation of
FKS1 and cell wall synthesis, or both [69]. These obser-
vations have lead to the idea that cell growth and sur-
vival is a product of signals derived from cell integrity
and nutrient availability [69]. In this work we provide
evidence for rescue of tor2ts lethality by the deletion of
the MYO1 gene. We propose that myo1Δ rescues the
tor2ts lethality by invoking both strategies described
above, namely, by activating a starvation type response
(TOR) and the cell wall integrity pathway (PKC1
CWIP), most likely through the reorganization of the
actin cytoskeleton. However, unlike the results of Car-
don et al. [69] where the essential Rho1p GEF was
Rom2p, the roles of Rom1p and Rom2p appear to be
redundant for the proposed myo1Δ rescue mechanism
(data not shown).
Conclusions
We have shown that cross-talk between the PKC1 and
TOR signaling cascades occur under the myo1Δ stress
condition. TORC1 activity was found to be inversely
correlated with activation of the PKC1 pathway while
both Tor1p and Pkc1p act as positive regulators of via-
bility in the myo1Δ strain. Synthetic rescue of tor2-21ts
lethality by myo1Δ points to the PKC1-dependent
reorganization of the actin cytoskeleton as the possible
rescue mechanism. The data presented supports that in
addition to its known role in signaling to the PKC1




Saccharomyces cerevisiae strains used in this study are
listed in Table 1. Dr. Brian C. Rymond kindly provided
the TOR1, SIT4 and WSC1 null mutation strains. The
myo1Δtor1Δ, myo1Δsit4Δ, myo1Δwsc1Δ and myo1Δ-
tor2Δptor2ts double mutants were constructed by adisruption of the MYO1 gene with a HIS5 module by
homologous recombination using a PCR based method.
Strains tor2ΔpTOR2 and tor2Δptor2ts were kindly pro-
vided by Dr. Michael N. Hall. The composition of
complete synthetic media (CSM) for wild type cells was
complemented with 2% Glucose and 1X Nitrogen base
without amino acids. The composition of rich medium
(YPD)/G for tor1Δ, sit4Δ, and wsc1Δ strains was com-
plemented with 2% Glucose and 200ug/mL G418
(Geneticin). Histidine dropout media (CSM HIS-) was
used for double mutant lacking the MYO1 gene; while
Leucine dropout media (CSM LEU-) was used for the
maintenance of plasmids, each one complemented with
2% Glucose and the appropriate nitrogen base without
amino acids. Cultures were grown overnight at 26°C to
mid-logarithmic phase with an optical density between
0.5–0.8 AU (OD600) with continuous shaking at
225 rpm. A 1 mg/mL stock solution of rapamycin
(SIGMA) was dissolved in the drug vehicle 100% DMSO.
To inhibit TORC1, cultures were treated with rapamycin
for 1 h with drug vehicle alone (DMSO) 100% or with a
half maximal (50%) growth inhibitory concentration of
rapamycin at a final concentration of 60nM (54.85 ng/
mL) for wt cells and 44nM (36.56 ng/mL) for mutant
cells, prior to harvesting. Cultures bearing plasmid
ptor2ts were grown to mid-log phase in CSM LEU-
medium, and were then diluted to an OD600 of 0.5 in
pre-warmed media. Cultures were shaken at 225 rpm at
37°C for 1 h.Plasmid and genetic techniques
Plasmid pHA-NPR1 (pEJ23) consists of YEplac181
(LEU2) expressing a functional N-terminally HA-tagged
NPR1 under its own promoter [53], kindly provided by
Dr. Estela Jacinto. Plasmid YCplac111::tor2-21ts (LEU2)
containing a temperature sensitive tor2-21ts allele [21]
was kindly provided by Dr. Michael N. Hall. Escherichia
coli strain DH5α was used for the propagation and isola-
tion of plasmids. Yeast transformations were performed
by the Lithium acetate procedure. Yeast plasmid DNA
was isolated by an adaptation from the QIAGEN QIA-
prep Spin miniprep kit.Western blot analysis
Whole yeast cell protein extracts were prepared by
harvesting and lysing cell cultures by vortexing with
glass beads for 20 s with 3 min intervals on ice
(repeated 3 times). Lysis buffer contained 50 mM
Tris–HCl pH 7.5, 10% Glycerol, 1% TritonX-100, 0.1%
SDS, 150mN NaCl, and 5 mM EDTA, supplemented
with 5X Protease Inhibitor Cocktail (50X stock; Roche)
and 10 mM PMSF. Cell lysates were centrifuged at
13,000 rpm for 10 min at 4°C; the supernatant was
Table 1 Strains used in this study
Strain Genotype Source
YJR12,YJR24_1 (wild type, wt) MAT α trp1 ura3 leu2-3 his3Δ1 met- ADE+ARG+ cyhR Lab. Strain
JK9-3da (wt’) MAT a leu2-3,112 trp ura3 rmel his4 HMLa M. Hall
YJR13 (myo1Δ) MAT a trp1 ura3 leu2-3 his3Δ1 met- ADE+ARG+ cyhR myo1Δ::HIS5+ Lab. Strain
YFR22 (fks1Δ) MAT α trp1-289 ura3-52 leu2-3, 112 his3Δ1 ADE+ARG+ cyhR fks1Δ::kanMX4 F. Rivera
YFR23 (chs2Δ) MAT α trp1-289 ura3-52 leu2-3, 112 his3Δ1 ADE+ARG+ cyhR chs2Δ::kanMX4 F. Rivera
YJR066W (tor1Δ) MAT α his3Δ1 leu2Δ0 lysΔ0 ura3Δ0 tor1Δ::kanMX4 B. Rymond
YGP1 (myo1Δtor1Δ) MAT α his3Δ1 leu2Δ0 lysΔ0 ura3Δ0 tor1Δ::kanMX4, myo1Δ::HIS5+ This study
YOR008C (wsc1Δ) MAT α his3Δ1 leu2Δ0 lysΔ0 ura3Δ0 wsc1Δ::kanMX4 B. Rymond
YES1 (myo1Δwsc1Δ) MAT α his3Δ1 leu2Δ0 lysΔ0 ura3Δ0 wsc1Δ::kanMX4, myo1Δ::HIS5+ E. Santiago
MH346-1a/pJK3-3 JK9-3da ade2 tor2::ADE2/pSEY18::TOR2 M. Hall
SH121 (tor2Δ ptor2ts) JK9-3da ade2 tor2::ADE2/YCplac111::tor2-21ts M. Hall
YGP5 (myo1Δtor2Δptor2ts) JK9-3da ade2 tor2::ADE2/YCplac111::tor2-21ts myo1Δ::HIS5+ This study
YJR12/pEJ23 (wt pHA-NPR1) MAT α trp1 ura3 leu2-3 his3Δ1 met- ADE+ARG+ cyhR, pHA-NPR1 This study
YJR13pEJ23 (myo1Δ pHA-NPR1) MAT a trp1 ura3 leu2-3 his3Δ1 met- ADE+ARG+ cyhR, myo1Δ::HIS5+pHA-NPR1 This study
(YFR22pEJ23) (fks1Δ pHA-NPR1) MAT α trp1-289 ura3-52 leu2-3, 112 his3Δ1 ADE+ARG+ cyhR fks1Δ::kanMX4,
pHA-NPR1
This study
YFR23pEJ23 (chs2ΔpHA-NPR1) MAT α trp1-289 ura3-52 leu2-3, 112 his3Δ1 ADE+ARG+ cyhR chs2Δ::kanMX4,
pHA-NPR1
This study
YJR066WpEJ23 (tor1ΔpHA-NPR1) MAT α his3Δ1 leu2Δ0 lysΔ0 ura3Δ0 tor1Δ::kanMX4, pHA-NPR1 This study
YGP1pEJ23 (myo1Δtor1Δ pHA-NPR1) MAT α his3Δ1 leu2Δ0 lysΔ0 ura3Δ0 tor1Δ::kanMX4 myo1Δ::HIS5+, pHA-NPR1 This study
YDL047W pEJ23 (sit4ΔpHA-NPR1) MAT α his3Δ1 leu2Δ0 lysΔ0 ura3Δ0 sit4Δ::kanMX4, pHA-NPR1 This study
YGP3pEJ23 (myo1Δsit4Δ pHA-NPR1) MAT α his3Δ1 leu2Δ0 lysΔ0 ura3Δ0 sit4Δ::kanMX4 myo1Δ::HIS5+, pHA-NPR1 This study
YOR008C pEJ23 (wsc1ΔpHA-NPR1) MAT α his3Δ1 leu2Δ0 lysΔ0 ura3Δ0 wsc1Δ::kanMX4, pHA-NPR1 This study
YES1pEJ23 (myo1Δwsc1Δ pHA-NPR1) MAT α his3Δ1 leu2Δ0 lysΔ0 ura3Δ0 wsc1Δ::kanMX4 myo1Δ::HIS5+, pHA-NPR1 This study
YJR24_1/YCplac111 (wt ptor2ts) MAT α trp1 ura3 leu2-3 his3Δ1 met- ADE+ARG+ cyhR, YCplac111::tor2-21ts This study
YJR13/YCplac111 (myo1Δ ptor2ts) MAT a trp1 ura3 leu2-3 his3Δ1 met- ADE+ARG+ cyhR myo1Δ::HIS5+,
YCplac111::tor2-21ts
This study
YFR23/pYCplac111 (chs2Δptor2ts) MAT α trp1-289 ura3-52 leu2-3, 112 his3Δ1 ADE+ARG+ cyhR chs2Δ::kanMX4,
YCplac111::tor2-21ts
This study
YJR13YCplac111pRS316MYO1 (myo1Δptor2tspMYO1) MAT a trp1 ura3 leu2-3 his3Δ1 met- ADE+ARG+ cyhR myo1Δ::HIS5+,
YCplac111::tor2-21ts pRS316MYO1
This study
YGP5pRS316MYO1 (myo1Δtor2Δptor2tspMYO1) JK9-3da ade2 tor2::ADE2, myo1Δ::HIS5+, YCplac111::tor2-21ts pRS316MYO1 This study
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method (Bio-Rad, Hercules, CA).
Whole protein extracts were denatured at 95°C for
5 min, separated on 10% SDS-polyacrylamide gels and
transferred to nitrocellulose membrane at 0.37 Amps for
1 h at 4°C in a Mini Trans Blot Cell (Bio-Rad, Hercules,
CA). Npr1p was consistently expressed more abundantly
in wt cells than in any of the mutant cells. Therefore,
the loading volumes were adjusted accordingly. The rea-
son for these differences in Npr1p levels between strains
is not known, but it has been speculated that it could be
due to differences in the stability of the protein [53]. For
analysis of HA-NPR1, membranes were probed with
anti-HA rat monoclonal antibody (3 F10, Roche, 1:1000)in blocking solution containing 0.5% Western Blocking
Reagent (Roche) diluted in 1X TBS (Tris Buffered Saline,
Sigma Aldrich) at 4°C overnight and washed in 1X TBS/
0.1% Tween-20 (TBS/T) (Sigma Aldrich). Membranes
were counter-probed with a Horseradish Peroxidase
(HRP) conjugated secondary Goat anti-rat IgG antibody
(Pierce, 1:5000). For phosphorylated Slt2p (P-Slt2p),
membranes were incubated with anti-phospho-p44/42
MAPK rabbit monoclonal antibody (Cell Signaling,
1:1000) in 5% BSA (Bovine Serum Albumin, Sigma
Aldrich) plus TBS/T buffer at 4°C overnight. HRP-
conjugated secondary antibody was Goat anti-rabbit IgG
antibody (Pierce, 1:10000) diluted in blocking solution.
For analysis of phosphorylated eukaryotic Initiation
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anti-phospho-eIF2α polyclonal antibody (Invitrogen,
1:1000) in blocking solution at 4°C overnight. Mem-
branes were stripped and reprobed with a rabbit poly-
clonal antibody that recognizes both the phosphorylated
and unphosphorylated forms of eIF2α (eIF2α)(kindly
provided by Dr. Thomas E. Dever). HRP-conjugated sec-
ondary antibody was Goat anti-rabbit IgG antibody
(Pierce, 1:10000) diluted in blocking solution. Mem-
branes were also probed with a mouse monoclonal anti-
body against Phosphoglycerate kinase (Pgk1p)
(Molecular Probes, Invitrogen, 1:500) as a loading
control.
Proteins were detected using a chemiluminescent sub-
strate (SuperSignal West Pico, Thermo Scientific), and
membranes were exposed to X-ray film, which were then
scanned with a Molecular Imager FX Pro Plus (Bio-Rad,
Hercules, CA). Digital image intensity was quantified
using Quantity One 4.5.2 software (BioRad). Protein
bands were quantified according to the ratio of the in-
tensity of the test protein relative to the intensity of its
Pgk1p loading control. The obtained values were aver-
aged from duplicate experiments. Quantitative units
were expressed as CNT*mm2 or Contour Quantity. This
is described as the sum of the intensities of all the pixels
within the band boundary multiplied by the area of each
pixel (Quantity One, Bio-Rad). Error bars represent the
Standard Error of the mean (STDError mean), calculated
as the standard deviation (STDEV)/Square root (SQRT)
of the count.Alkaline phosphatase (PPase) treatment of
protein extracts
To generate dephosphorylated proteins, 50 μg of whole
yeast cell protein extract were incubated with 50U (1U/
μg) of Calf Intestinal Alkaline Phosphatase (CIP or
PPase, New England Biolabs) in the presence of 1X CIP
buffer (10X NEB 3, New England Biolabs) and 5X Prote-
ase Inhibitors cocktail, EDTA Free (50X stock, Roche)
for 30 min at 37°C. Samples were denatured at 95°C for
5 min and subjected to SDS-PAGE and Western
blot analysis.Viability assay
Wt, myo1Δ, tor1Δ, myo1Δtor1Δ, wsc1Δ and myo1Δwsc1Δ
strains were grown to OD600 between 0.5–0.8 AU at
26°C with continuous shaking at 226 rpm. 5uL of ser-
ial dilutions ranging from 1x107–1x102 cells/mL were
spotted onto CSM or selection media agar plates con-
taining 2% Glucose and 1X Nitrogen base. Plates were
incubated at 26°C to observe growth after three days
of incubation. Strains expressing the temperature sensi-
tive tor2-21ts mutation were streaked on CSM orselection media agar plates, and were incubated at 26°C
and 37°C for 2.5 days.
Additional file
Additional file 1: Pagán-Mercado, Santiago-Cartagena, Akamine,
and Rodríguez-Medina. Assay for viability of yeast strains by growth at
26°C and 37°C in Leucine-deficient dropout agar medium. Strains wt
(YJR24), myo1Δ, chs2Δ, wt’ (JK9-3da), tor2Δ ptor2ts, wt ptor2ts, myo1Δ
ptorts, chs2Δ ptor2ts, tor2Δ pTOR2, myo1Δtor2Δptor2ts were tested for
presence of the ptor2ts plasmid containing the LEU2 marker.
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